scroll over
the diagram
to learn more


Our goal is to acquire drug candidates and rely on a single expert team of experienced pharmaceutical industry veterans to rapidly move them forward to clinical proof of concept.

Many early stage companies find themselves run aground on the hard rocks of economic reality: it takes an enormous amount of money to take a promising idea to market. From proof in the lab to proof in man can take many years. Often these companies have multiple compounds that could be blockbuster medicines, but they can’t afford to develop them all.

Our goal is to beat historic trends in time to proof of concept by creating a virtual pharmaceutical development company that focuses on the most critical valuation inflection point: from proof in the lab to proof in man.